IRIS
GIOVATI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.145
AS - Asia 3.112
EU - Europa 2.188
SA - Sud America 400
AF - Africa 216
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.069
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.049
SG - Singapore 1.054
CN - Cina 828
IT - Italia 559
VN - Vietnam 523
BR - Brasile 320
IE - Irlanda 316
DE - Germania 251
SE - Svezia 250
FI - Finlandia 219
HK - Hong Kong 188
ZA - Sudafrica 140
BD - Bangladesh 102
AT - Austria 93
GB - Regno Unito 92
TR - Turchia 89
FR - Francia 88
NL - Olanda 88
IN - India 72
CA - Canada 65
UA - Ucraina 53
RU - Federazione Russa 52
JP - Giappone 45
BE - Belgio 31
ID - Indonesia 31
KR - Corea 30
ES - Italia 28
AR - Argentina 23
IQ - Iraq 20
MX - Messico 20
PK - Pakistan 18
CZ - Repubblica Ceca 17
EC - Ecuador 16
PH - Filippine 14
PL - Polonia 13
KE - Kenya 12
TH - Thailandia 12
EG - Egitto 11
CO - Colombia 10
UZ - Uzbekistan 10
MA - Marocco 9
TW - Taiwan 9
AZ - Azerbaigian 8
LT - Lituania 8
NP - Nepal 8
HU - Ungheria 7
JO - Giordania 7
SA - Arabia Saudita 7
VE - Venezuela 7
TN - Tunisia 6
UY - Uruguay 6
BJ - Benin 5
BO - Bolivia 5
CI - Costa d'Avorio 5
IL - Israele 5
LK - Sri Lanka 5
NG - Nigeria 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
DZ - Algeria 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
EU - Europa 3
KZ - Kazakistan 3
LV - Lettonia 3
MY - Malesia 3
OM - Oman 3
PT - Portogallo 3
SN - Senegal 3
ZW - Zimbabwe 3
AL - Albania 2
AM - Armenia 2
AU - Australia 2
CM - Camerun 2
CY - Cipro 2
JM - Giamaica 2
LB - Libano 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PY - Paraguay 2
RO - Romania 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
Totale 10.052
Salva come PNG Salva come JPEG
Città #
Dallas 601
Ashburn 554
Singapore 539
Chandler 367
San Jose 319
Dublin 304
Santa Clara 246
Ann Arbor 213
Parma 199
Hong Kong 179
Beijing 173
Ho Chi Minh City 167
Johannesburg 135
Dearborn 120
Hanoi 117
Los Angeles 103
New York 102
Boardman 100
Vienna 88
Munich 80
Nanjing 72
Shanghai 71
Council Bluffs 62
Izmir 61
Princeton 59
Bremen 55
Jacksonville 55
Lauterbourg 54
Hefei 44
Wilmington 43
Shenyang 35
Milan 34
Buffalo 33
Haiphong 33
Turku 33
Helsinki 30
Moscow 30
Brussels 29
Jinan 28
Columbus 27
Fortaleza 26
Nanchang 26
Da Nang 25
Seoul 24
São Paulo 24
Hebei 22
Woodbridge 22
The Dalles 21
Tokyo 21
Toronto 21
Atlanta 20
Des Moines 20
Rome 20
San Mateo 20
Chennai 19
Denver 19
Verona 19
Jakarta 18
Seattle 18
Houston 17
Orem 17
London 16
Brooklyn 15
Changsha 15
Grafing 15
Hillsboro 15
Montreal 15
Nuremberg 15
Kunming 13
Reggio Nell'emilia 13
Rio de Janeiro 12
Tianjin 12
Hangzhou 11
Modena 11
Nakano 11
Frankfurt am Main 10
Fremont 10
Istanbul 10
Phoenix 10
San Francisco 10
Tashkent 10
Warsaw 10
Washington 10
Can Tho 9
Düsseldorf 9
Guangzhou 9
Jiaxing 9
Norwalk 9
Poplar 9
Pune 9
Morishita 8
Nairobi 8
Stockholm 8
Alto Reno Terme 7
Amman 7
Basingstoke 7
Belo Horizonte 7
Bengaluru 7
Biên Hòa 7
Bologna 7
Totale 6.438
Salva come PNG Salva come JPEG
Nome #
Killer Peptide-Containing Polyelectrolytic Nanocomplexes to Fight Toxoplasma gondii Infection 248
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 247
Antibacterial effects of two synthetic peptides against Enterococcus faecalis biofilms: A preliminary in vitro study 226
Biological behavior of human gingival fibroblasts and formation of microbial biofilm on 3D-printed dental resin restorations 223
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 221
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 215
Anti-Staphylococcus aureus Activity and Structural Characterization of Rationally Designed Peptides 205
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 203
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 201
Activity of two antimicrobial peptides against Enterococcus faecalis in a model of biofilm-mediated endodontic infection 198
Candidacidal activity of a novel killer toxin from Wickerhamomyces anomalus against fluconazole-susceptible and -resistant strains 193
Antibodies as a source of anti-infective peptides: an update 191
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 189
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 189
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 183
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 182
Screening of thiosemicarbazones as antimycotic drugs 179
Anti-Herpetic Activity of Killer Peptide (KP): An In Vitro Study 178
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 176
Antimicrobial peptide L18R displays a modulating action against inter-kingdom biofilms in the Lubbock chronic wound biofilm model 176
Activity of Synthetic Peptide KP and Its Derivatives against Biofilm-Producing Escherichia coli Strains Resistant to Cephalosporins 174
Metabolic profiling of Candida albicans 173
Fungicidal activity of peptides encoded by immunoglobulin genes 167
Antifungal activity of the C-terminal peptide from human serum albumin 165
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 165
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 163
Antibody peptide based antifungal immunotherapy 155
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 154
Peptides from the inside of the antibodies are active against infectious agents and tumours 154
Novel Arginine- and Proline-Rich Candidacidal Peptides Obtained through a Bioinformatic Approach 153
Natural and synthetic peptides with antifungal activity 150
Antibody-mediated protective immunity in fungal infections 149
Metabolic Plasticity of Candida albicans in Response to Different Environmental Conditions 149
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 142
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 141
Oral and maxillofacial fungal infections 141
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 139
Mode of action of a killer peptide against Toxoplasma gondii 138
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 137
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 136
Chimeric symbionts expressing a Wolbachia protein stimulate mosquito immunity and inhibit filarial parasite development 136
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 135
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 133
Metabolic profile of Candida albicans 132
Wickerhamomyces yeast killer toxins’ medical applications 132
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 132
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 131
In vitro and in vivo anticandidal activity of killer peptide derivatives 126
Innate antimicrobial and antiviral activities of antibody peptides 123
The Variability of the Salivary Antimicrobial Peptide Profile: Impact of Lifestyle 122
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 121
Candidacidal properties of peptides encoded by immunoglobulin genes 112
Relazione struttura-funzione di un peptide fungicida derivato dalla regione costante di immunoglobuline G umane 108
The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action 107
Ogni frammento anticorpale può esplicare attività antinfettiva ed antitumorale. 104
Single residue contribution to self-aggregation of a fungicidal immunoglobulin-derived peptide 103
Therapeutic effect of an antibody-derived peptide in a Galleria mellonella model of systemic candidiasis 103
Vaccine for the prevention of Aflatoxin B1 carry over in the milk of lactating dairy cows 102
From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy 99
Vaccination of heifers with anaflatoxin improves the reduction of aflatoxin B₁ carry over in milk of lactating dairy cows 98
Mimotopi killer sintetici 94
Dissection of the structural features and fungicidal activity of an antibody-derived peptide 91
Therapeutic effects of an antibody-derived peptide and its alanine scanning derivatives in a Galleria mellonella model of systemic candidiasis 88
Screening of a Saccharomyces cerevisiae nonessential gene deletion collection for altered susceptibility to a killer peptide 88
Isolation of a Wickerhamomyces anomalus yeast strain from the sandfly Phlebotomus perniciosus, displaying the killer phenotype 79
Yeast killer toxins technology transfer 76
Interkingdom interactions between Candida albicans and Enterococcus faecalis in dual-species biofilms 75
Potential improvement of cheese safety by vaccination of dairy cows: a focus on Anaflatoxin B1. 73
In vitro evaluation of L18R peptide’s antibiofilm activity against mono- and dual-species biofilms of Candida albicans and Enterococcus faecalis 38
Investigating L18R peptide antibiofilm activity and microbial interactions in dual-species biofilms of Candida albicans and Enterococcus faecalis 35
In silico designed antibody-derived peptides: structural characterization and evaluation of antibacterial activity 32
Killer Peptide-containing polyelectrolytic nano complexes to fight toxoplasma gondii infection 2
Studi sull'immunizzazione nei confronti di aflatossine 1
Totale 10.199
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 0 0 43
2021/2022358 23 5 23 39 24 23 21 33 16 24 19 108
2022/20231.335 132 142 93 119 167 158 7 89 386 5 25 12
2023/2024624 30 47 21 38 56 159 40 51 20 47 53 62
2024/20251.802 37 79 99 148 138 249 59 87 251 167 169 319
2025/20264.513 341 580 589 403 540 235 437 209 489 359 201 130
Totale 10.199